Novartis beats Q3 estimates and raises FY2026 core operating income guidance
FROM THE WIRE · SEEKINGALPHA.COM
* Novartis press release [https://www.novartis.com/sites/novartis_com/files/q3-2026-media-release-en.pdf] (NVS [https://seekingalpha.com/symbol/NVS]): Q3 Non-GAAP EPS of $2.46 beats by $0.22. * Revenue of $14.52B (+4.4% Y/Y) misses by $40M. * Q3 net sales grew +4% (cc1, +4%…
Read at the source ↗MARKET IMPACTHIGH✦ News Impact agent estimateTone: expected bullishA mega-cap raises core operating income guidance, a factor that can move the stock and the pharma sector.AI-generated summary
✦ IN BRIEF · AIAI-generated summary
- 01Novartis reports Q3 non-GAAP EPS of $2.46, beating by $0.22.
- 02Revenue of $14.52B grows 4.4% but misses estimates by $40M.
- 03Core operating income guidance moves from low single-digit decline to low single-digit growth.
NEWS IMPACT AND MARKET REACTIONChange since the story · reference
Impact and summary are estimates by the News Impact AI agent, not financial advice.Open in Markets